Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

Published:2019-09-05 Issue:11 Volume:8 Page:e1656502
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Xie Wei¹²³⁴,Forveille Sabrina¹²³⁴,Iribarren Kristina¹²³⁴^ORCID,Sauvat Allan¹²³⁴^ORCID,Senovilla Laura¹²³⁴,Wang Yan¹²³⁴,Humeau Juliette¹²³⁴,Perez-Lanzon Maria¹²³⁴^ORCID,Zhou Heng¹²³⁴,Martínez-Leal Juan F.⁵,Kroemer Guido¹²³⁴⁶^ORCID,Kepp Oliver¹²³⁴^ORCID

Affiliation:

1. Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France

2. Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France

3. Université Paris Descartes, Sorbonne Paris Cité, Paris, France

4. Université Pierre et Marie Curie, Paris, France

5. PharmaMar, Madrid, Spain

6. Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1656502

Reference26 articles.

1. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

2. Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors

3. Calreticulin exposure dictates the immunogenicity of cancer cell death

4. Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

5. The immune contexture in cancer prognosis and treatment

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate;Clinical Genitourinary Cancer;2024-10

2. Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them;Frontiers in Oncology;2024-08-09

3. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment;Biomedicine & Pharmacotherapy;2024-08

4. Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study;Lung Cancer;2024-08

5. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer;Acta Pharmaceutica Sinica B;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3